X4 Pharmaceuticals, Inc. · NASDAQ:XFOR
Trails Edge Capital Partners, LP reported a 5.80% stake in X4 Pharmaceuticals, Inc. (Schedule 13G/A)
Event Dec 31, 2025 · Filed Feb 17, 2026
Trails Edge Capital Partners, LP reported a 5.80% stake in X4 Pharmaceuticals, Inc., 5,227,222 shares, as a passive investor on Dec 31, 2025. Filed Feb 17, 2026 (Schedule 13G/A).
- Stake
- 5.80%
- Shares
- 5,227,222
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Trails Edge Capital Partners, LP | 5.80% | 5,227,222 |
| Trails Edge Biotechnology Master Fund, LP | 5.80% | 5,227,222 |
| Ortav Yehudai | 5.80% | 5,227,222 |
Source
Related
- X4 Pharmaceuticals, Inc.
- Trails Edge Capital Partners, LP
- X4 Pharmaceuticals, Inc. shareholders
- Schedule 13G · Trails Edge Capital Partners, LP · Aug 18, 2025
- Form 4 · Craig Adam R · Oct 19, 2026
- Schedule 13G/A · FMR LLC · Oct 7, 2026
- Form 4 · Kirske David · Oct 5, 2026
- Schedule 13G · Venrock Healthcare Capital Partners III, L.P. · Sep 21, 2026
- Schedule 13G/A · Deep Track Capital, LP · Aug 14, 2026